|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2004-4-6
|
|
pubmed:abstractText |
Studies in experimental models and preliminary clinical experience suggested a possible therapeutic role for the soluble tumor necrosis factor antagonist etanercept in heart failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:BorerJeffrey SJS,
pubmed-author:ColucciWilson SWS,
pubmed-author:DjianJacquesJ,
pubmed-author:DrexlerHelmutH,
pubmed-author:FeldmanArthurA,
pubmed-author:FlemingThomasT,
pubmed-author:KoberLarsL,
pubmed-author:KrumHenryH,
pubmed-author:LiuPeterP,
pubmed-author:MannDouglas LDL,
pubmed-author:McMurrayJohn J VJJ,
pubmed-author:NieminenMarkkuM,
pubmed-author:PackerMiltonM,
pubmed-author:SwedbergKarlK,
pubmed-author:TavazziLuigiL,
pubmed-author:WaldenstromAndersA,
pubmed-author:WarrenMarshelleM,
pubmed-author:WestheimArneA,
pubmed-author:ZannadFaiezF,
pubmed-author:van VeldhuisenDirk JanDJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
6
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1594-602
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15023878-Adolescent,
pubmed-meshheading:15023878-Adult,
pubmed-meshheading:15023878-Aged,
pubmed-meshheading:15023878-Aged, 80 and over,
pubmed-meshheading:15023878-Disease Susceptibility,
pubmed-meshheading:15023878-Double-Blind Method,
pubmed-meshheading:15023878-Female,
pubmed-meshheading:15023878-Heart Failure,
pubmed-meshheading:15023878-Hospitalization,
pubmed-meshheading:15023878-Humans,
pubmed-meshheading:15023878-Immunoglobulin G,
pubmed-meshheading:15023878-Infection,
pubmed-meshheading:15023878-Life Tables,
pubmed-meshheading:15023878-Male,
pubmed-meshheading:15023878-Middle Aged,
pubmed-meshheading:15023878-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:15023878-Survival Analysis,
pubmed-meshheading:15023878-Treatment Failure,
pubmed-meshheading:15023878-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).
|
|
pubmed:affiliation |
Winters Center for Heart Failure Research, Baylor College of Medicine and the Houston VA, Houston, Tex 77030, USA. dmann@bcm.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
